J. Minatta

Prediction of severe toxicity in adult patients under treatment with 5-fluorouracil: a prospective cohort study

W. Belloso, F. Angriman, M. Pallotta, 2017, Anti-cancer drugs.

Efficacy and Safety of Nivolumab in Previously Treated Patients With Non-Small-cell Lung Cancer: Real World Experience in Argentina.

M. Rizzo, G. Recondo, R. Kowalyszyn, 2020, Clinical lung cancer.

Tumor desmoide abdominal

F. Wright, S. Specterman, J. Minatta, 2018, Oncología Clínica.

P86.18 Prevalence, Clinical Characteristics and Survival of Patients with KRAS Mutant Lung Cancer in Argentina.

V. Denninghoff, G. Recondo, H. Rivello, 2021 .

P84.22 Outcomes of TKI Treatment in Patients with NSCLC Harboring Uncommon EGFR Mutations: A Real-World Study in Argentina

M. Rizzo, C. Martín, G. Recondo, 2021 .

Nivolumab plus docetaxel in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer: results from the phase II CheckMate 9KD trial.

F. Saad, A. Armstrong, D. Shaffer, 2021, European journal of cancer.

RET-MAP: An international multi-center study on clinicobiologic features and treatment response in patients with lung cancer harboring a RET fusion.

E. Felip, D. Planchard, V. Ludovini, 2023, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Severe toxicity in adult patients with lung cancer under treatment with pemetrexed: a prospective cohort study

W. Belloso, M. Pallotta, H. Díaz de Arce, 2019, Journal of chemotherapy.

Optimal Therapeutic Strategy for PD-L1 Negative Metastatic Non-Small Cell Lung Cancer: A Decision-Making Guide Based on Clinicopathological and Molecular Features

M. Rizzo, M. Malvicini, J. Minatta, 2023, Current Treatment Options in Oncology.

Efficacy and safety of nivolumab in combination with docetaxel in men with metastatic castration-resistant prostate cancer in CheckMate 9KD

C. Drake, D. Shaffer, A. Saci, 2019, Annals of Oncology.

Digital Commons@Becker Digital

F. Saad, A. Ravaud, A. Armstrong, 2023 .